HemoShear Therapeutics

About:

HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.

Website: http://www.hemoshear.com

Top Investors: Small Business Innovation Research, Janus Henderson Investors, Adage Capital Management, Suvretta Capital Management, Jaffray Woodriff

Description:

HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders. It creates human-relevant systems to accurately replicate the biology of organ systems and diseases for use throughout drug discovery and development. They work strategically in partnerships with pharmaceutical, biotechnology, and medical device companies. It generates meaningful human response data to increase confidence in decision-making, reduce the risk of costly failures, and identify efficacious therapies.